Abivax S.A. Stock
Your prediction
Abivax S.A. Stock
The Abivax S.A. stock is trending slightly upwards today, with an increase of €0.10 (0.680%) compared to yesterday's price.
For the coming years our community has positive and negative things to say abot the Abivax S.A. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Valuation (undervalued/overvalued)" there were negative voices in the community.
Pros and Cons of Abivax S.A. in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Abivax S.A. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Abivax S.A. | 0.680% | - | - | - | - | - | - |
Valneva SE | 0.800% | -2.718% | -4.127% | -18.057% | -26.442% | -69.549% | 3.787% |
Nanobiotix | -3.450% | 4.106% | -4.570% | 157.869% | -17.056% | -59.902% | -53.534% |
Transgene S.A. | -4.120% | -10.526% | 15.625% | -29.799% | -6.119% | -49.376% | -56.471% |
Comments
DERFY stimmt der Outperform-Einschätzung der institutionellen Analysten zu
DERFY stimmt am 12.07.2016 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 26.97€ zu.News
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax publishes financial reports with the French and U.S. securities regulatory agencies
EQS-News: Abivax reports 2023 financial results and operational update
EQS-News: Abivax reports 2023 financial results and operational update
EQS-News: Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
EQS-News: Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)